Skip to content

Clinical trials

Sleep Initiation and Maintenance Disorders trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Status: Unknown status Clear all

296 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20054
20062
20072
20083
20094
20104
20115
20124
20134
20145
20155
201610
201716
201818
201920
202029
202137
202242
202341
202435
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status296

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong11
Chinese University of Hong Kong6
Taipei Veterans General Hospital, Taiwan6
NHS Greater Glasgow and Clyde5
Chang Gung Memorial Hospital3
China Academy of Chinese Medical Sciences3
China Medical University Hospital3
Nanfang Hospital, Southern Medical University3
National Taiwan University Hospital3
Shanghai Mental Health Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders296
Anxiety Disorders41
Sleep Wake Disorders26
Fatigue17
Parasomnias15
Pain13
Stress Disorders, Post-Traumatic7
Chronic Pain6
Cognitive Dysfunction6
Inflammation6

Trials

Showing 76 to 100 of 296. Each trial links to its page on Pharma Observatory.

196 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.